Martin Shkreli (Dennis Van Tine/Sipa USA)(Sipa via AP Images)
Nine years and four generics later, the HIV drug at the center of the Shkreli controversy still has a high price
Years after Martin Shkreli kicked off a drug pricing controversy around the HIV drug Daraprim, the price of the drug has not fallen to pre …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
